Biohaven Therapeutics Ltd.

This study tested whether a new drug called BHV-7000 could safely reduce symptoms of major depression. It involved 336 adults with moderate to severe depression who were not taking other depression medications. Researchers compared the drug to a placebo over 6 weeks, measuring ch…

This study tested whether an experimental drug called BHV-7000 could safely and effectively treat acute manic episodes in people with bipolar I disorder. Researchers enrolled 274 hospitalized patients and compared BHV-7000 against a placebo over 21 days, measuring changes in mani…

This study tested a new medicine called BHV-2100 to see if it can safely and effectively stop migraine headaches. About 647 people with migraines received either the drug or a placebo pill when a migraine started. Researchers measured how many people were pain-free and free of th…